First Time Use of SD-809 in Huntington Disease

Study Title
First Time Use of SD-809 in Huntington Disease
Teva Identifier
SD-809-C-15
ClinicalTrials.gov Identifier
NCT01795859
Study Status
Completed
Trial Condition(s)
Chorea
Interventions
Drug: SD-809 | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations
brain-icon

Key Participation Requirements

Gender
Female, Male
Age group
Adult, Older Adult
Age Range
18 Years and older
Trial Duration
08/05/2013 - 12/05/2014
Phase
Phase 3

Study Type

Interventional